SCHEMBL9310239

SCHEMBL9310239

CCc1nc(Cl)c(C(=O)OCC(=O)N(CC)CC)n1Cc1c2ccocc-2c(Br)c1-c1ccccc1-c1nnn(C(c2ccccc2)(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9312408 0.94 AGTR1 (0.34) AGTR1
SCHEMBL9311079 0.90 AGTR1 (0.33) AGTR1
SCHEMBL9313688 0.90 AGTR1 (0.36) AGTR1
SCHEMBL9309386 0.90 AGTR1 (0.38) AGTR1
SCHEMBL9312195 0.89 AGTR1 (0.37) AGTR1
SCHEMBL9310878 0.87 AGTR1 (0.40) AGTR1
SCHEMBL9309238 0.87 AGTR1 (0.33) AGTR1
SCHEMBL9694973 0.86 AGTR1 (0.31) AGTR1
SCHEMBL9308994 0.85 AGTR1 (0.40) AGTR1
SCHEMBL9309384 0.85 AGTR1 (0.32) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US disclosed